| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 10/07/2009 | CN101553228A Treatment of fibrosing disorders |
| 10/07/2009 | CN101549131A Traditional Chinese medicine formula for treating prostatitis |
| 10/07/2009 | CN101549126A Traditional Chinese medicine composition for treating prostatitis and preparation method thereof |
| 10/07/2009 | CN101549113A Traditional Chinese medicine composition for treating urinary system stones and preparation method thereof |
| 10/07/2009 | CN101549087A Compound golden gardenia capsule |
| 10/07/2009 | CN101549076A Preparation method of micropills of six drugs with rehmannia |
| 10/07/2009 | CN101549052A Traditional Chinese medicine combination for treating vesical calculus |
| 10/07/2009 | CN101549049A Chinese medicinal combination for treating acute nephritis and chronic nephritis |
| 10/07/2009 | CN101549041A Yang-tonifying kidney-protecting pill |
| 10/07/2009 | CN101548995A Application of Viscum album extract as NF-kB inhibitor |
| 10/07/2009 | CN101548956A Sub-micro emulsion frozen preparation of aztreonam |
| 10/07/2009 | CN101548920A Folk prescription for curing prostatosis by traditional Chinese medical science |
| 10/07/2009 | CN100547003C Antibodies to human IL-1 beta |
| 10/07/2009 | CN100546977C New compounds for the inhibition of rotamases and use thereof |
| 10/07/2009 | CN100546642C Chinese traditional medicine composition for treating nephritis |
| 10/07/2009 | CN100546598C Oral liquid for eliminating dropsy and improving kidney function |
| 10/07/2009 | CN100546596C Clerodendranthus spicatus anti-urinary-stone extract and preparing method thereof |
| 10/06/2009 | US7598293 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 10/06/2009 | US7598284 Indazole compounds as B3 adrenoceptor agonist |
| 10/06/2009 | US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 10/06/2009 | US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 10/06/2009 | US7598253 Reverse-turn mimetics and methods relating thereto |
| 10/06/2009 | US7598244 (S)-1-(3-ethoxy-1-methylpropyl)-3-[7-(3,4-methylenedioxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]urea; preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease |
| 10/06/2009 | US7598242 Compounds for the treatment of inflammatory disorders |
| 10/06/2009 | US7598228 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death |
| 10/06/2009 | US7598045 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer |
| 10/01/2009 | WO2009120803A2 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator |
| 10/01/2009 | WO2009120799A2 Methods of treating fibrotic disorders |
| 10/01/2009 | WO2009119858A1 Benzene compound, and use thereof for medical purposes |
| 10/01/2009 | WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 10/01/2009 | WO2009119692A1 Novel glycolipid and use thereof |
| 10/01/2009 | WO2009119652A1 USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF α INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR |
| 10/01/2009 | WO2009061448A9 Methods and compositions for the treatment of proteinuric diseases |
| 10/01/2009 | US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease |
| 10/01/2009 | US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 10/01/2009 | US20090247528 Method of treating attention deficit disorder |
| 10/01/2009 | US20090246855 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 10/01/2009 | US20090246303 Method for Reducing The Effects of Chemotherapy Using Flagellin Related Polypeptides |
| 10/01/2009 | US20090246209 Gnrh analogues for treatment of urinary incontinence |
| 10/01/2009 | CA2719853A1 Methods of treating fibrotic disorders |
| 10/01/2009 | CA2719290A1 Use of benzophenone derivative or salt thereof and tnf.alpha. inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 10/01/2009 | CA2718436A1 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator |
| 09/30/2009 | EP2105141A1 Short bioactive peptides and methods for their use |
| 09/30/2009 | EP2105139A1 Method of producing a dry earthworm powder |
| 09/30/2009 | EP2104508A2 Treating acute renal failure with soluble thrombomodulin variants |
| 09/30/2009 | EP0983076B1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease |
| 09/30/2009 | CN101543546A Antioxidative substance and composition and use thereof |
| 09/30/2009 | CN101543540A Compound medicinal charcoal |
| 09/30/2009 | CN101543523A Uyghur drug compound recipe extracting technology for chiccory |
| 09/30/2009 | CN101543521A Rape pollen soft capsule and method for preparing same |
| 09/30/2009 | CN101543517A Folium ginkgo total flavonoid aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543490A Application of genistein in medicament preparation for treating hyperplasia of prostate, product and producing method |
| 09/30/2009 | CN100544711C Prostate hyperplasia preventing prescriptions |
| 09/29/2009 | US7596455 Crystallization of IGF-1 |
| 09/29/2009 | US7595341 Analogues of lipid mediators derived from ω-3 PUFAs and methods of use |
| 09/29/2009 | US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 09/29/2009 | US7595316 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 09/29/2009 | US7595301 Staple type oligonucleotide and drug comprising the same |
| 09/29/2009 | CA2457944C Polycyclic guanine phosphodiesterase v inhibitors |
| 09/29/2009 | CA2383983C Substituted indolealkanoic acids |
| 09/29/2009 | CA2347105C Controlled-release pharmaceutical composition with gastric residence |
| 09/29/2009 | CA2318208C Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/29/2009 | CA2259148C Solid oral dosage forms of valsartan |
| 09/29/2009 | CA2176796C Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 09/24/2009 | WO2009116382A1 Inhibitor for blood phosphorus level elevation |
| 09/24/2009 | US20090239929 N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors |
| 09/24/2009 | US20090239928 N-Pyrrolidin-3YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors |
| 09/24/2009 | US20090239886 Substituted xanthine derivatives |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239805 Human 3 relaxin |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239295 Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use |
| 09/24/2009 | US20090238812 Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery |
| 09/24/2009 | CA2716676A1 Inhibitor for blood phosphorus level elevation |
| 09/23/2009 | EP2103624A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/23/2009 | EP2103613A1 Quinoxaline derivative |
| 09/23/2009 | EP2103607A1 1-phenyl 1-thio-d-glucitol derivative |
| 09/23/2009 | EP2103598A1 Fluorinated cycloalkyl-derived benzoylguanidine, method for producing same, use of same as medicine and medicine containing same |
| 09/23/2009 | EP2101575A2 Ace2 activator compounds and methods of use thereof |
| 09/23/2009 | CN101538518A Hippocampus liquor for warming kidney and strengthening yang and production method |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101538218A Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 09/23/2009 | CN101537182A Combination comprising an HMG CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 09/23/2009 | CN101537161A Chinese patent drug for treating nephritis |
| 09/23/2009 | CN101537154A Manufacturing method of medicament for treating ten kinds of diseases |
| 09/23/2009 | CN101537137A Chinese material medical preparation for treating urinary infection |
| 09/23/2009 | CN101537136A Chinese herbal medicine composition for treating hematuria caused by blood deficiency and blood heat |
| 09/23/2009 | CN101537099A Chinese traditional medicine composition for curing chronic nephritis and preparation method thereof |
| 09/23/2009 | CN101537096A Method for controlling quality of Chinese medicinal preparation for treating chronic prostatitis |
| 09/23/2009 | CN101537077A Chinese medicinal mixed tincture |
| 09/23/2009 | CN101537029A Preparation method for extract of cornel containing ursolic acid |
| 09/23/2009 | CN101537002A Diacerein composition with good leaching property, and preparation and use thereof |
| 09/23/2009 | CN100543016C Intermediate compound of 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592359 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 09/22/2009 | US7592356 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 09/22/2009 | US7592010 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 09/22/2009 | US7591949 Method for the improvement of transport across adaptable semi-permeable barriers |